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ABSTRACT: Natural products isolated from marine environment are well known for their pharmacody-
namic potential in diversity of disease treatments such as cancer or inflammatory conditions. Sea cucum-
bers are one of the marine animals of the phylum Echinoderm. Many studies have shown that the sea
cucumber contains antioxidants and anti-cancer compounds. Chronic lymphocytic leukemia (CLL) is a
disease characterized by the relentless accumulation of CD51 B lymphocytes. CLL is the most common
leukemia in adults, about 25–30% of all leukemias. In this study B lymphocytes and their mitochondria
(cancerous and non-cancerous) were obtained from peripheral blood of human subjects and B lympho-
cyte cytotoxicity assay, and caspase 3 activation along with mitochondrial upstream events of apoptosis
signaling including reactive oxygen species (ROS) production, collapse of mitochondrial membrane
potential (MMP) and mitochondrial swelling were determined following the addition of Holothuria parva
extract to both cancerous and non-cancerous B lymphocytes and their mitochondria. Our in vitro finding
showed that mitochondrial ROS formation, MMP collapse, and mitochondrial swelling and cytochrome c
release were significantly (P<0.05) increased after addition of different concentrations of H. parva only in
cancerous BUT NOT normal non-cancerous mitochondria. Consistently, different concentrations of
H. parva significantly (P< 0.05) increased cytotoxicity and caspase 3 activation only in cancerous BUT
NOT normal non-cancerous B lymphocytes. These results showed that H. parva methanolic extract has a
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selective mitochondria mediated apoptotic effect on chronic lymphocytic leukemia B lymphocytes hence
may be promising in the future anticancer drug development for treatment of CLL. VC 2016 Wiley Periodicals,
Inc. Environ Toxicol 00: 000–000, 2016.
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chondria
INTRODUCTION
Environment has been a source of medicinal products for
millennia, with many useful drugs developed from environ-
mental sources. While marine organisms do not have a sig-
nificant history of use in traditional medicine, the ancient
Phoenicians employed a chemical secretion from marine
molluscs to produce purple dyes for woolen cloth, and sea-
weeds have long been used to fertilize the soil. The world’s
oceans, covering more than 70% of the earth’s surface, rep-
resent an enormous resource for the discovery of potential
chemotherapeutic agents. The systematic investigation of
marine environments as sources of novel biologically active
agents only began in earnest in the mid-1970s. During the
decade from 1977 to 1987, about 2500 new metabolites
were reported from a variety of marine organisms and, to
keep in perspective (Cragg and Newman, 2013).
The sea cucumber belongs to the Echinoderm phylum. It
has been a traditional tonic food in many Asian countries for
thousands of years. Many species have been found, among
them only several species are edible and of medicinal use
(Salarzadeh et al., 2012). The sea cucumbers live on soft
sediments, phanerogam sea grass beds and rocky substrata,
in depths between 0 and 100 m (Colloca et al., 1997). In the
oceans, there are hundreds of varieties of sea cucumbers.
Sea cucumbers are famous to exert beneficial effects on
human health. Traditionally these echinoderms are used in
many Asian countries as a medicine for maintain fitness dur-
ing long fishing travels or to prevent, reduce or cure several
illness like renal deficiency, arthritis or constipation. Several
articles published in the last decades came in support to
these medicinal purposes showing several biological activi-
ties of sea cucumber extracts as antimicrobial, anticancer,
and immunomodulatory properties and exhibiting wound
healing promoter (Ridzwan et al., 1995; Fredalina et al.,
1999; Aminin et al., 2001; Tian et al., 2005).
Chronic lymphocytic leukemia (CLL) is an illness char-
acterized by an accumulation of monoclonal mature B cells
in the peripheral blood. Although CLL is the most common
leukemia in the Western world, little is known about the
biology of the disease (Chiorazzi et al., 2005). Treatment
schemes rely heavily on glucocorticoids, chlorambucil, and
nucleoside analogs (Hallek et al., 2008). However, despite
the initial effectiveness of these drugs in patients with low-
grade disease, resistant cells ultimately emerge, leaving no
effective treatment options available. It is possible that drug-
resistant CLL cells possess intrinsic defect(s) in their ability
to undergo apoptosis (Dean et al., 2005). Many investigators
have shown that all of natural compounds trigger apoptosis
in CLL cells in vitro through intrinsic pathway (mitochon-
dria), suggesting that induction of apoptosis may account for
their therapeutic efficacy. Mitochondria, the cells power-
houses, are essential for maintaining cell life, and they also
play a major role in regulating cell death, which occurs upon
permeabilization of their membranes (Green and Reed,
1998; Ravagnan et al., 2002; Breckenridge and Xue, 2004;
Green and Kroemer, 2004).Once mitochondrial membrane
permeabilization (MMP) occurs, cells die either by apoptosis
or necrosis. Key factors regulating MMP include calcium,
the cellular redox status (including levels of reactive oxygen
species) and the mobilization and targeting to mitochondria
of Bcl-2 family members. Contemporary approaches to tar-
geting mitochondria in cancer therapy use strategies that
either modulate the action of Bcl-2 family members at the
mitochondrial outer membrane or use specific agents that
target the mitochondrial inner membrane and the mitochon-
drial permeability transition (PT) pore (Fagian et al., 1990;
Gadelha et al., 1997; Kopustinskiene et al., 2001; Armstrong
and Jones, 2002). Activation of the cell death machinery in
cancer cells by inhibiting tumour-specific alterations of the
mitochondrial metabolism or by stimulating mitochondrial
membrane permeabilization could therefore be promising
therapeutic approaches (Fulda et al., 2010).
In our study we isolated B lymphocytes from CLL
patients and normal lymphocytes from healthy donors. Then
we investigated selective toxicity of methanolic extract of H.
parva on B lymphocytes obtained from CLL patients.
Because mitochondria is a major pathway for induction of
apoptosis in cells, mitochondrial upstream events such as
mitochondrial functionality, mitochondrial swelling, ROS
formation, collapse of mitochondrial membrane potential,
and finally cytochrome C release were also investigated on
mitochondria isolated from B lymphocytes of both CLL
patients and healthy donors.
MATERIALS AND METHODS
Sampling
Samples of H. parva with helping of divers at depth 6–9 m
were collected at Bandar Abbas on the Persian Gulf coast of
Iran. The samples put in large containers containing seawa-
ter with good aeration and were transferred to laboratory,
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Iranian Fisheries Research Institute, Persian Gulf, and Oman
Sea Ecological Research Center.
Sample Identification
To ensure the accuracy of the species, a slice of epidermal
tissue sample with thickness of 1 mm and area 1 cm2 were
parted and then in a test tube containing 3 mL of liquid
bleach was placed. After 20 min, a white precipitate was col-
lected at the end of the tube. A drop of white sediment was
spread on a lam and then was observed by light microscopy
with lenses 10 and 40. Ossicles with key FAO identification
of sea cucumbers for H. parva were compared.
Anatomy
Once in the laboratory, the samples were divided into sepa-
rate components that consist of body wall, respiratory tree,
gonad, and digestive tube. Different parts of the H. parva
body was cut into pieces of 1–2 cm and was kept at 208C.
Extraction
Samples after dissection, for better performance and durabil-
ity in a period of 24–48 h were put in freezer-drier device, to
make them dry and frozen. The methanol extract was pre-
pared. Dried-frozen samples were transferred to an Erlen-
meyer flask containing methanol remained to be extracted
for 48 h. Extract by rotarod apparatus, at temperatures <408
were concentrated. After the required time, pure extract was
prepared as dry (Salarzadeh et al., 2012).
Standardization of Extract
Total phenols were determined using Ciocalteau’s method.
Total phenol content was calculated as a gallic acid equiva-
lent using calibration curves prepared with gallic acid stan-
dard solutions. Total phenols in samples were 1086 7 mg of
gallic acid equivalents/100 g. Total flavonoids were deter-
mined using aluminum chelating method of Kovacevic.
Total flavonoids content was calculated as a rutin equiva-
lents using calibration curves prepared with rutin hydrate
standard solutions covering a concentration range between
10 and 50 mg ml21. The amount of total flavonoids in sam-
ples was 316 3.2 mg of rutin equivalents/100 g (Mamelona
et al., 2007).
Selection Healthy Donors or Patients with
CLL
The 10 CLL patients (6 males and 4 females) aged 58–85
years (with median age of 63 years) were enrolled in this
study. CLL was diagnosed and confirmed according to defi-
nition of the World Health Organization (WHO) classifica-
tion by oncologist. Only those patients showing no previous
treatments within the last 6 months were included in the pre-
sent study. All 10 patients were sampled prior to the
commencement of any treatment and at least 2 weeks after
the transfusion. Age-matched controls were obtained from
10 healthy donors. This study was approved by the Shahid
Beheshti University of Medical Science’sethics committee
and all the patients and healthy controls signed an informed
consent form (Salimi et al., 2015b).
Isolation Lymphocytes
Lymphocytes from venous blood of healthy donors or
patients with CLL were prepared by Ficoll–Hypaque density
gradient centrifugation. The peripheral blood lymphocytes
were maintained in RPMI 1640 supplemented with 10%
FCS and used further in the experiments. The percentage of
CD51/CD191 (leukemic) cells in the samples from patients
with CLL was determined by flow cytometry, using mono-
clonal mouse anti-human antibodies, CD5 FITC/CD19 PE.
It was added stromal cell-derived factor21 to rescue B-
lymphocytes from apoptosis Then the cells were counted
and cells at density of 106/mL were adjusted (Salimi et al.,
2015b).
Cytotoxicity Assay
The effect of the Acacetin on lymphocytes obtained from
healthy donors or patients with CLL was investigated using
MTT assay. Briefly, the cells were seeded in 96-well culture
plates at a density of 10,000 cells per well. The acacetin was
added to various final concentrations (0, 5, 10, 20, 50, 100,
and 200 mM) in triplicates. After 24 h of incubation with
acacetin, 25 mL of MTT reaction solution (5 mg mL21 in
RPMI 1640 medium) was added to the wells. The optical
density was read at 580 nm wavelength in an ELISA plate
reader after 4-h incubation of the plates with MTT in an
incubator (378C and 5% CO2-air). All determinations were
confirmed using replication from at least three identical
experiments (Liu et al., 1997).
Determination of Caspase-3 Activity
Caspase-3 activity was measured in cell lysate of lympho-
cytes from different treatments using caspase-3 assay kit
(“Sigma’s CASP- 3-C).” Briefly, this colorimetric assay is
based on the hydrolysis of substrate peptide, Ac- DEVD-
pNA, through caspase-3 (Pourahmad et al., 2010a; Salimi
et al., 2015b).
Determination of Protein Concentration and
Normalized Data
The Bradford assay is very fast for determination of protein
concentration. The assay is based on the observation that the
absorbance maximum for an acidic solution of Coomassie
Brilliant Blue G-250 shifts from 465 to 595 nm when bind-
ing to protein occurs. We prepared a standard curve of absor-
bance versus micrograms protein with albumin (0, 500,
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1000, 1500, and 2000 mg mL21) and determine amounts
from the curve. Final concentration of isolated mitochondria
was adjusted in 1000 micrograms per milliliter in corre-
sponding buffer (Faizi et al., 2014; Hosseini et al., 2013).
Cell Lysis and Isolation of Mitochondria
Mitochondria were isolated from the lymphocytes by
mechanical lysis and differential centrifugation. Briefly, cells
were washed with cold PBS at 48C and centrifuged at
1300 RPM. The pellet was resuspended in cold isolation
buffer (75 mmol L21 sucrose, 20 mmol L21 HEPES, 225
mmol L21 mannitol, 0.5 mmol L21 EDTA, pH 7.2), and the
cells were disrupted by homogenization. Nonlysed cells and
nuclei were spun down by centrifugation at 1000 g for 10
min. The supernatant was further spun at 20,000g for 25
min. The pellet, designated as the mitochondrial fraction,
was suspended in related buffer. The isolation of mitochon-
dria was determined by measurement of succinate dehydro-
genase (Salimi et al., 2015b).
Measurement of Succinate Dehydrogenase
Briefly, mitochondria obtained from patients and healthy
donors was suspended in assay buffer (140 mmol L21 KCL,
10 mmol L21 NaCl, 2 mmol L21 MgCl2, 0.5 mmol L
21
KH2PO4, 20 mmol L
21 HEPES, 0.5 mmol L21 EGTA;
adjusted to pH 7.2 with KOH), The assay buffer was supple-
mented with 1 mg mL21 rotenone and 10 mmol L21 succi-
nate immediately before use. The mitochondria were seeded
in 96-well culture plates at a density of 100 mg mL21 per
well. The acacetin was added to various final concentrations
(0, 5, 10, 20, 50, 100, and 200 mM) in triplicates. After 1 h
of incubation with acacetin, 25 mL of MTT reaction solution
(0.4% MTT in assay buffer including succinate) was added
to the wells. The optical density was read at 580 nm wave-
length in an ELISA plate reader after 30-min incubation of
the plates with MTT in an incubator. All determinations
were confirmed using replication from at least three identical
experiments (Pourahmad et al., 2011; Salimi et al., 2015a).
Determination of Mitochondrial Swelling
Purified mitochondria were isolated as described above.
Mitochondria suspensions (at 100 Ag protein per well) were
incubated in 96-well plates at 258C in assay buffer (140
mmol L21 KCl, 10 mmol L21 NaCl, 2 mmol L21 MgCl2,
0.5 mmol L21 KH2PO4, 20 mmol L
21 HEPES, 0.5
mmol L21 EGTA; adjusted to pH 7.2 with KOH) supple-
mented with 1 mg mL21 rotenone and 10 mmol L21 succi-
nate. Various compounds were added after 10 min of
preincubation. The mPTPC inhibitor such as cyclosporine A
was added upon initiation of the preincubation period. Mito-
chondrial swelling was measured spectrophotometrically.
This method equates mitochondrial membrane permeability
transition with high amplitude swelling of the mitochondria.
Mitochondrial swelling results in a decrease in absorbance
monitored at 540 nm (Talari et al., 2014).
Determination of the Collapse of
Mitochondrial Membrane Potential (MMP)
Mitochondrial uptake of the cationic fluorescent dye, rhoda-
mine 123, has been used for the estimation of mitochondrial
membrane potential. The mitochondrial fractions (1000 mg
protein/mL) were incubated with 10 lM of rhodamine 123
in MMP assay buffer (220 mM sucrose, 68 mM D-mannitol,
10 mM KCl, 5 mM KH2PO4, 2 mM MgCl2, 50 lM EGTA,
5 mM sodium succinate, 10 mM HEPES, 2 lM Rotenone).
The fluorescence was monitored using Shimadzu RF-5000U
fluorescence spectrophotometer at the excitation and emis-
sion wavelength of 490 and 535 nm, respectively (Pourah-
mad and O’Brien, 2000; Rezaei et al., 2014).
Determination of Mitochondrial ROS
The mitochondrial ROS measurement was performed using
the fluorescent probe DCFH-DA. Briefly, isolated mitochon-
dria from both group of lymphocytes and were placed in res-
piration buffer (0.32 mM sucrose, 10 mM Tris, 20 mM
Mops, 50 lM EGTA, 0.5 mM MgCl2, 0.1 mM KH2PO4 and
5 mM sodium succinate) Following this step, DCFH-DA
was added (final concentration, 10 lM) to mitochondria and
then incubated for 10 min. Then, the fluorescence intensity
of DCF was measured using Shimadzu RF-5000U fluores-
cence spectrophotometer at an excitation wavelength of
488 nm and emission wavelength of 527 nm (Pourahmad
et al., 2009; Salimi et al., 2015b).
Determination of Cytochrome C Release
The concentration of cytochrome c was determined through
using the Quantikine human Cytochrome c Immunoassay kit
provided by R and D Systems (Minneapolis, MN). Briefly, a
monoclonal antibody specific for rat/mouse cytochrome c
was precoated onto the microplate. Seventy-five lL of con-
jugate (containing monoclonal antibody specific for cyto-
chrome c conjugated to horseradish peroxidase) and 50 lL
of control and test group were added to each well of the
microplate. One microgram of protein from each supernatant
fraction was added to the sample wells. All of the standards,
controls and test were added to two wells of the microplate.
After 2 h of incubation, the substrate solution (100 lL) was
added to each well and incubated for 30 min. After 100 lL
of the stop solution was added to each well; the optical den-
sity of each well was determined through the aforemen-
tioned microplate spectrophotometer set to 450 nm
(Pourahmad et al., 2010b; Rezaei et al., 2014).
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Western Blot Analysis
The treated CLL B-lymphocytes were collected and lysed in
a buffer lysis contained 20 mM Tris-HCl (pH 7.5), 1 mM
EDTA, 150 mM NaCl, 50 mM NaF, 10 mM sodium pyro-
phosphate, 1 mM sodium orthovanadate, 2 mM phenyl-
methyisulfonylfluoride, 0.5% Triton-X as well as protease
inhibitor cocktail on ice for 15 min. The protein concentra-
tions of cell lysates were measured with the Bradford meth-
od. The proteins were equally loaded on and separated by
SDS-PAGE gel, and then transferred to nitrocellulose mem-
branes with moisture transfer technique at 100 V for 2 h.
The membranes were blocked by incubation with 5% defat-
ted milk PBS solution for 1 h. After washing, the membranes
were incubated in a solution of monoclonal antibodies
against human cytochrome c, procaspase-9, caspase 9,
procaspase-3, and caspase-3 (in dilution 1:1000) for 1 h,
respectively. The rabbit anti-mouse IgG antibodies (1:1000)
were used as the secondary antibody. Immunoreactive bands
were visualized by the ECL kit (Pierce) and the gray densi-
ties were measured with GDS-8000 imaging system (UVP,
USA).
Statistical Analysis
Results are presented as mean6SD. Assays were performed
in triplicate and the mean was used for statistical analysis.
Statistical significance was determined using the one-way
ANOVA test, followed by the post-hoc Tukey test when
appropriate. Statistical significance was set at P< 0.05. And
the parameters of mitochondrial dysfunction were analyzed
by two way ANOVA and Bonferonie posttest. In all graph
were expressed as mean6 SEM and P< 0.05 was consid-
ered statistically significant.
RESULTS
Viability Assay
Evaluation of sea cucumber H.parva methanolic extract for
potential selective toxicity on B lymphocytes cells obtained
from CLL patients was carried out using the MTT assay. A
250 mg mL21 concentration of extract reduced 20% of can-
cerous B lymphocytes viability following 24 h of exposure
(Fig. 1 graph B). Toxicity evaluation in normal lymphocytes
obtained from healthy donors revealed no significant
decrease in cell viability at the same concentration of 250
mg mL21 (Fig. 1 graph A).
Caspase 3 Assay
Caspase-3 is activated in the cell under apoptosis signaling
through both extrinsic (death ligand) and intrinsic (mito-
chondrial) pathways. As shown in Figure 2, H. parva metha-
nolic extract significantly increased the activity of apoptosis
final mediator, caspae-3 in CLL BUT NOT healthy B-
lymphocytes. To figure out the upstream mechanism
involved in H.parva methanolic extract induced caspase-3
activation we examined the pretreating effect of Z-IETD a
caspase 8 inhibitor and cyclosporine A (Cs.A), an MPT pore
sealing agent and Butylated hydroxytoluene (BHT), a ROS
scavenger on H. parva methanolic extract treated CLL B-
lymphocytes. Our results showed that only Cs.A and BHT
Fig. 1. Cell viability. Effect of H.parva methanolic extract on cell viability in normal and cancerous B lymphocytes. Cells were
treated with H.parva methanolic extract and cell viability was measured by MTT assay following 24 h of extract addition. Val-
ues were expressed as mean6SD of three separate determinations (graph A and B). ***: Significant difference in comparison
with untreated control (P<0.001). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.
com.]
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but not Z-IETD prevented H.parva methanolic extract
induced caspase 3 activation (P< 0.001) suggesting that H.
parva methanolic extract activates a ROS-mediated mito-
chondrial intrinsic pathway in cancerous B-lymphocytes
which could end in apoptosis.
Succinate Dehydrogenase Activity
Studying the inhibitory effects of sea cucumber H. parva
methanolic extract on succinate dehydrogenase activity in
the mitochondria obtained from B lymphocytes of both CLL
patients and normal healthy donors were carried out by
MTT assay. H. parva methanolic extract strongly inhibited
succinate dehydrogenase activity in a dose-dependent man-
ner in cancerous BUT NOT healthy mitochondria (Fig. 3
graph B, graph A).
ROS Formation Assay
We examined whether the level of ROS in cancerous and
normal mitochondria are affected by H. parva methanolic
extract using DCF-staining. As shown in Figure 4, graph
B, H. parva methanolic extract treatment at 50, 100, and
200 mg mL21 concentrations for 1 h, significantly induced
ROS generation (P< 0.05) in cancerous mitochondria.
These results suggested that H. parva methanolic extract
induced ROS generation might underlie its effect on pro-
moting CLL cell apoptosis. However as shown at Figure 4
graph A, treatment with H. parva methanolic extract at 50,
100, and 200 mg mL21 concentrations for 1 h, did not
induce ROS generation in normal mitochondria. Further-
more, 10 mM cyclosporine A (an MPT blocker) and 50 mM
BHT (antioxidant scavenger) strongly inhibited ROS for-
mation induced by H. parva in CLL B- lymphocyte mito-
chondria (P <0.05).
Fig. 2. CLL and healthy B-lymphocytes (106 cells mL21)
were incubated in RPMI 1640 medium in conventional con-
dition (378C and 5% CO2-air) following the addition of H.
parvamethanolic extract to both groups. As shown in Figure
2, H. parva methanolic extract significantly increased the
activity of caspae-3 in CLL B-lymphocytes BUT NOT
healthy B-lymphocytes. However only Cs.A (5 mM) and BHT
(5 mM) but not Z-IETD (10 mM) prevented extract induced
caspase 3 activation. Values are expressed as mean6SD
of three separate experiments (n55). ***: Significant differ-
ence in comparison with healthy control (P< 0.001). [Color
figure can be viewed in the online issue, which is available
at wileyonlinelibrary.com.]
Fig. 3. Effect of H. parva methanolic extract on succinate dehydrogenase activity in both normal and cancerous B lympho-
cytes mitochondria. Mitochondria were treated with H. parva methanolic extract and succinate dehydrogenase activity was
measured by MTTassay following 1 h of extract exposure. Values are mean6SD of three separate experiments (graph A and
B). ***: Significant difference in comparison with untreated control (P<0.001). [Color figure can be viewed in the online issue,
which is available at wileyonlinelibrary.com.]
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MMP Assay
To search for the mechanisms involved in apoptosis, we
examined the effects of H. parva methanolic extract on
mitochondrial membrane potential (DWm) mitochondria iso-
lated from both groups. Addition of different concentrations
of extract (50, 100, and 200 mg mL21) for 1 h showed
decreased DWm in mitochondria obtained from CLL B lym-
phocytes in comparison to their corresponding untreated
control (Fig. 5, graph B). On the other hand, addition of
same concentrations of extract (50, 100, and 200 mg mL21)
on normal mitochondria did not show any significant
decrease at DWm in comparison to those of their untreated
control (Fig. 5, graph A). Furthermore, 10 mM cyclosporine
A (an MPT blocker) and 50 mM BHT (antioxidant scaven-
ger) strongly inhibited the decline of MMP induced by H.
parva in CLL B- lymphocyte mitochondria (P< 0.05).
Mitochondrial Swelling
Induction of mitochondrial swelling in isolated lymphocyte
mitochondria was monitored by following 540 nm
absorbance (A540) decrease. Addition H. parva methanolic
extract (50, 100, and 200 mg mL21) resulted in an extensive
mitochondrial swelling in cancerous mitochondria obtained
from B lymphocytes of CLL patients (Fig. 6, graph B).
Addition of same concentrations (50, 100, and 200
mg mL21) of extract to normal mitochondria did not induce
mitochondrial swelling (Fig. 5, graph A).
Cytochrome C
Our results showed that H. parva methanolic extract signifi-
cantly caused mitochondrial swelling and collapse of the
mitochondrial membrane potential. These events could result
in mitochondrial permeability transition and release of cyto-
chrome c from mitochondria into the incubation buffer. As
shown in Figure 7, H. parva methanolic extract (100
mg mL21) induced significant (P< 0.05) release of cyto-
chrome c on the liver mitochondria isolated from CLL
patients but not normal healthy donors. Significantly, the
pretreatment of extract-treated mitochondria with the MPT
inhibitor, cyclosporine A (Cs.A) and ROS scavenger, butyl-
ated hydroxyl toluene (BHT) prevented cytochrome c
Fig. 4. The effect of H. parvamethanolic extract on ROS formation in both normal and cancerous mitochondria. Freshly isolated
purified mitochondria were obtained from both healthy donors and CLL patients and then incubated with H. parva methanolic
extract for 1 h. ROS was measured spectroflourimetrically by DCF staining. The mean fluorescence intensity of DCF was
enhanced by extract in comparison to control for each group during 1 h of exposure. ****: Significant difference in comparison
with untreated control (P< 0.0001). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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Fig. 5. The effect of H. parva methanolic extract on DWm collapse. Freshly isolated purified mitochondria from both healthy
and CLL B lymphocytes were treated with different concentrations of extract (50, 100, and 200 mg mL21) for 1 h. DWm was
measured by rhodamine 123 staining with spectrofluorescence method. Our data revealed that H. parva methanolic extract
could induce a significant decrease in DWm only in cancerous CLL but not in normal mitochondria obtained from healthy
donors (graph B, graph A). ****: Significant difference in comparison with untreated control (P< 0.0001). [Color figure can be
viewed in the online issue, which is available at wileyonlinelibrary.com.]
Fig. 6. H. parva methanolic extract induced mitochondrial swelling. Addition of H. parva methanolic extract (50, 100, and 200
mg mL21) induced mitochondrial swelling in cancerous BUT NOT normal mitochondria. For swelling evaluation, absorbance of
mitochondrial suspensions at 540 nm were monitored every 15 min within 1 h. ***: Significant difference in comparison with
untreated control (P< 0. 001). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.]
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release as compared with sole H. parva methanolic extract-
treated group (100 mg mL21) (P< 0.05), indicating the role
of oxidative stress and MPT pore opening in extract induced
cytochrome c release.
Western Blotting Analysis
To examine whether H. parva methanolic extract may
induce apoptosis through mitochondrial pathway, we mea-
sured the levels of cytochrome c, procaspase 3 and 9 and
caspase 3 and 9 of CLL cells after 12 of incubation with H.
parva methanolic extract. Western blot experiments revealed
that, H. parva methanolic extract decreased procaspase 3
and 9 expression while that of caspase 3 and 9 were
increased (Fig. 8). Also level of cytochrome c in cytosolic
fraction markedly increased compared with its level in mito-
chondrial fraction. These data suggested that H. parva meth-
anolic extract induced apoptosis through an intrinsic
mitochondrial pathway in CLL cells.
DISCUSSION
Sea cucumber is an important ingredient in traditional medi-
cine and has been considered to be a food among the many
communities since ancient times. This traditional science
has been further subscribed by scientific studies of its biolog-
ical potential with biomedical importance (Bordbar et al.,
2011). In an attempt to search for new lead natural products
with potent biological activities, for the first time we carried
out a selective anti-cancer evaluation of the methanolic
extract of Holothuria parva. Our findings showed selective
toxicity of H. parva methanolic extract on cancerous B lym-
phocytes and their mitochondria obtained from CLL patients
by MTT assay (Figs. 1 and 3, graph B) while this extract
didn’t show any significant toxicity effect on normal lym-
phocytes obtained from healthy donors and their mitochon-
dria (Figs. 1 and 3, graph A). Because the cancer is the
second leading worldwide cause of death after cardiovascu-
lar diseases, this finding enjoys significant importance (Wije-
singhe et al., 2013).
Many anti-tumor agents are reported to exert their anti-
cancer effects by inducing apoptosis of cancer cells (Kame-
saki, 1998). Apoptosis is an important biological mechanism
that contributes to the maintenance of the integrity of multi-
cellular organisms. Apoptotic cell death can be mediated via
several pathways that called extrinsic (receptor) and intrinsic
(mitochondria) pathways. Our results proved that H. parva
methanolic extract could selectively induce apoptosis in
CLL but not healthy normal B-lymphocytes and also showed
that this selective apoptosis is initiated from mitochondria
(Fig. 2). The mitochondrial permeability transition is an
important step in induction of cellular apoptosis (Zhang
et al., 2012). Many chemotherapeutic agents can target mito-
chondrial damage, eventually leading to cell death. In addi-
tion, many agents induce cellular stress, which may also
lead to mitochondrial perturbation and, finally, cell death. A
mechanism causing the mitochondrial dysfunction is mito-
chondrial membrane permeability transition which includes
dissipation of the inner membrane potential, osmotic swell-
ing of the matrix, rupture of the outer mitochondrial mem-
brane, release of cytochrome c, and other apoptogenic
proteins from the mitochondria, and formation of the
Fig. 7. Effect of the methanolic extract of H. parva (100
mg mL21) on the cytochrome c release in the lymphocyte
mitochondria isolated from CLL patients group. As shown in
this figure, pretreatment of with BHT or CsA significantly
prevented cytochrome c release in the cancerous lympho-
cyte mitochondria. The amount of expelled cytochrome c
from mitochondrial fraction into the suspension buffer was
determined by man Cytochrome c ELISA kit as described in
above. Values presented as mean6SD of five separate
experiments (n5 5). *# Minimal significance level P< 0.05.
[Color figure can be viewed in the online issue, which is
available at wileyonlinelibrary.com.]
Fig. 8. The effect of H. parva methanolic extract (100
mg mL21) on expression of cytochrome c, procaspase 3 and
9 and caspase 3 and 9 of CLL B-lymphocytes. CLL B-
lymphocytes were treated with H. parva methanolic extract
for 12 h. At the end of treatment, CLL B-lymphocytes were
collected and both the mitochondrial and cytosolic extracts
were prepared. Cytochrome c, procaspase 3 and 9, and
caspase 3 and 9 were measured by Western blotting. Band
1, untreated CLL B-lymphocytes control; 2, 100 mg mL21 H.
parva methanolic extract treated CLL B-lymphocytes.
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caspase-3 activation complex (Fulda et al., 2010). In this
study we showed increased ROS formation after exposure of
H. parva extract on cancerous mitochondria while the same
effect was NOT observed on normal mitochondria. The
mitochondrial respiratory chain is one of the major sources
of endogenous ROS (Green and Kroemer, 2004). Several
chemotherapeutic agents have been identified that promote
mitochondrial ROS generation, for example; mitochondrial
electron transport chain modulators (e.g., arsenic trioxide),
redox-cycling compounds (e.g., motexafin gadolinium), or
disrupt mitochondrial antioxidant defenses, i.e. GSH deplet-
ing agents (e.g., buthionine sulfoximine, phenethyl isothio-
cyanate), and inhibitors of SOD (e.g., 2-methoxyestradiol),
and catalase (e.g., 3- amino 21,2,4-triazole) (Pelicano et al.,
2003). ROS are responsible for induction of Ca2 dependent
mitochondrial permeability transition (MPT), with swelling
of the mitochondrial matrix and rupture of the OMM (Byrne
et al., 1999; Maciel et al., 2001). MMP is a universal feature
of cell death and is often considered as the “point of no
return” in the cascade of events leading to apoptosis (Chipuk
et al., 2004; Green and Kroemer, 2004). Our results also
revealed collapse mitochondria membrane potential (MMP)
only on cancerous mitochondria confirming that MMP
occurs after extract treatment on cancerous but not normal
mitochondria. Besides, addition of extract to cancerous mito-
chondria also resulted in mitochondrial swelling while this
did not happen on normal mitochondria at same extract con-
centration. Several mechanisms for the release of Cyt c from
mitochondria have so far been proposed in the literature,
including dissociation of this peptide from the inner mito-
chondrial membrane in response to cardiolipin peroxidation
by reactive oxygen species (ROS) (Gogvadze et al., 2006).
Several researchers have proposed that the release of Cyt c
occurs due to the rupture of the mitochondrial outer
membrane (Ott et al., 2002). Permeability transition involves
the opening of a channel named permeability transition pore
complex (MPT pore) (Javadov et al., 2009). In this study we
showed release of Cyt c from only cancerous mitochondria
after treatment with H. parva extract (100 mg mL21). More-
over, Cs A and BHT pretreatment completely blocked the
extract-induced release of cytochrome c from the cancerous
mitochondria which supports the hypothesis that the apopto-
sis induction via H. parva extract is due to an oxidative
stress and depends on the opening of the mitochondrial tran-
sition pores (Fig. 9).
Finally our results suggest that H. parva can act promis-
ing as an anticancer drug candidate by directly and selective-
ly targeting mitochobndria in cancerous cells and thus could
induce cell death through ROS mediated mitochondrial path-
way which finally ends in cytochrome c release, caspase 3
activation and apoptosis in cancerous B-lymphocytes isolat-
ed from CLL patients.
The results presented in this article were partly extracted from
the thesis of Dr. Maryam Ayatollahi (Pharm.D. graduate of Faculty
of Pharmacy, Shahid Beheshti University of Medical Sciences)
who performed their theses under the supervision of Prof. Jalal
Pourahmad and Prof. Abbasali Motallebi. The investigation was
performed in Prof. Jalal Pourahmad’s laboratory in the Faculty of
Pharmacy, Shahid Beheshti University of Medical Sciences, Teh-
ran, Iran. This work was financially support˜ed by a research grant
(Grant No: 14603/211) from the Research and Education and
Extension Organization (AREEO), Ministry of Jihad-e-Agriculture,
Tehran, Iran.
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